Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Cardiac Toxicity in Recipients of Hematopoietic Stem Cell Transplant with Post Transplant Cyclophosphamide

Allison Gradone, Xia Bi, Satya Durugu, Boula Gattas, Alicia Bao, ArponaDev Nath, Joanne Filicko-O'Hara, Brenda Grande, Gina Mateja, William O'Hara, John Wagner, Dolores Grosso, Neal Flomenberg, Usama Gergis

Blood (2024) 144 (Supplement 1): 2176.

https://doi.org/10.1182/blood-2024-211954

Published: 2024

Journal Articles

Letermovir Prophylaxis Is Effective in Preventing CMV Reactivation and Is Associated with Decreased Non-Relapse Mortality in Two-Step Allogeneic Stem Cell Transplantation

Matthew J Tucker, Marc Yorker, Joanne Filicko-O'Hara, William O'Hara, Usama Gergis, Gina Keiffer, Xia Bi

Blood (2024) 144 (Supplement 1): 7320.

https://doi.org/10.1182/blood-2024-208745

Published: 2024

Journal Articles

TBI-Based Myeloablative Conditioning Two-Step Haploidentical Allogeneic Hematopoietic Stem Cell Transplant Yields Excellent Outcomes in Fit Patients with High-Risk Hematologic Malignancies, Results of a Prospective Trial

Boula Gattas, Xia Bi, Dolores Grosso, Alicia Bao, Allison Gradone, Brenda Grande, Gina Mateja, Arpona Dev Nath, Joanne Filicko-O'Hara, William O'Hara, John Wagner, Neal Flomenberg, Usama Gergis

Blood (2024) 144 (Supplement 1): 509.

https://doi.org/10.1182/blood-2024-211147

Published: 2024

Journal Articles

A Novel Chemo-Based Reduced Intensity Haploidentical Two-Step Allogeneic Hematopoietic Stem Cell Transplantation, Results of a Prospective Clinical Trial

Alicia Bao, Xia Bi, Allison Gradone, Boula Gattas, Arpona Dev Nath, Brenda Grande, Gina Mateja, Joanne Filicko-O'Hara, William O'Hara, John Wagner, Dolores Grosso, Neal Flomenberg, Usama Gergis

Blood (2024) 144 (Supplement 1): 4891.

https://doi.org/10.1182/blood-2024-211810

Published: 2024

Journal Articles

Low Disease Relapse and High Survival in Non-Myeloablative Two-Step Haploidentical Transplant, Results of a Prospective Trial

Xia Bi, Dolores A. Grosso, John L. Wagner, Joanne Filicko-O'Hara, William O'Hara, Neal Flomenberg, Usama Gergis

Blood (2023) 142 (Supplement 1): 4908.

https://doi.org/10.1182/blood-2023-178779

Published: 2023

Journal Articles

Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience

Yang Yang, Adam F. Binder, Xia Bi, Joanne Filicko-O'Hara, William O'Hara, Neal Flomenberg, Dolores A. Grosso, John L. Wagner, Arpona Dev Nath, Sikemi Ibikunle, Eliabeth Spitz, Usama Gergis

Blood (2023) 142 (Supplement 1): 7110.

https://doi.org/10.1182/blood-2023-173576

Published: 2023

Journal Articles

Characteristics and Clinical Outcomes of Patients with Acute Myeloid Leukemia with TP53 Mutations - a Single Center Experience

Xia Bi, Zoe Begun, Dolores A. Grosso, Margaret Kasner, Gina Keiffer, Joanne Filicko-O'Hara, William O'Hara, John L. Wagner, Lindsay Wilde, Neal Flomenberg, Zixuan Wang, Usama Gergis

Blood (2023) 142 (Supplement 1): 2847.

https://doi.org/10.1182/blood-2023-179931

Published: 2023

Journal Articles

The Two-Step Approach to Haploidentical Transplant: Can Altering Timing in the Conditioning Regimen Increase Graft Versus Tumor Effects?

Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, Shannon Rudolph, John L. Wagner, Usama Gergis, Neal Flomenberg

Blood (2021) 138 (Supplement 1): 1845.

https://doi.org/10.1182/blood-2021-146913

Published: 2021

Journal Articles

Encouraging Results of Haploidentical Transplantation in Older Patents Using the Two-Step T Cell Tolerization Platform - Results of a Prospective Trial

Dolores Grosso, DNP, CRNP, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, John L. Wagner, MD, William O'Hara, PharmD, Shaik Rashid, MD, Gina Mateja, BA, Usama Gergis, MD, Neal Flomenberg, MD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-136377

Published: 2020

Journal Articles

The Two-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HI HSCT): 15 Years of Transplants in Patients 19-78 Years Old

Dolores Grosso, DNP, CRNP, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, John L. Wagner, MD, William O'Hara, PharmD, Shaik Rashid, MD, Usama Gergis, MD, Neal Flomenberg, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-139866

Published: 2020

Journal Articles

High Survival in Patients with Myelofibrosis Undergoing a Two-Step Approach to Hematopoietic Stem Cell Transplantation (HSCT): Effects of Donor Source and Pre-HSCT Splenic Therapy on Outcomes

Shaik Rashid, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, John L. Wagner, MD, William O'Hara, PharmD, Usama Gergis, MD, Neal Flomenberg, MD, Dolores Grosso, DNP, CRNP

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-139630

Published: 2020

Journal Articles

2 Step Myeloablative Haploidentical Transplant (HI MA HSCT) in Intermediate and High-Risk Patients-Changing the Timing of the 2 Step Approach

Dolores Grosso, DNP, CRNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Neil Palmisiano, MD, William O'Hara, PharmD, John L Wagner, MD, Pierluigi Porcu, MD, Neal Flomenberg, MD

Blood (2018) 132 (Supplement 1): 4661.

https://doi.org/10.1182/blood-2018-99-110815

Published: 2018

Journal Articles

HSCT Engraftment Kinetics: Differences in Chimerism between Haploidentical (HI) and Matched Related (MR) Transplant Recipients (HSCT) after the 2 Step Approach

Dolores Grosso, DNP, CRNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Margaret Kasner, MD, Thomas R. Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, Neil Palmisiano, MD, Pierluigi Porcu, MD, William O'Hara, PharmD, John L Wagner, MD, Neal Flomenberg, MD

Blood (2018) 132 (Supplement 1): 3371.

https://doi.org/10.1182/blood-2018-99-117364

Published: 2018

Journal Articles

The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

Dolores Grosso, DNP, CRNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD, Margaret Kasner, MD, Thomas Klumpp, MD, Ubaldo Martinez-Outschoorn, MD, William O'Hara, PharmD, Neil Palmisiano, MD, John L. Wagner, MD, Pierluigi Porcu, MD, Neal Flomenberg, MD

Blood (2017) 130 (Supplement 1): 1959.

https://doi.org/10.1182/blood.V130.Suppl_1.1959.1959

Published: 2017

Journal Articles

A 2 Step Approach To Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Low Non-Relapse Related Mortality (NRM) and High Overall Survival (OS) Rates Confirmed In Second Generation Trial

Dolores Grosso, DNP, Onder Alpdogan, MD, Matthew Carabasi, MD, Joanne Filicko-O'Hara, MD, Margaret Kasner, MD, Ubaldo Martinez, MD, William O'Hara, PharmD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2013) 122 (21): 3360.

https://doi.org/10.1182/blood.V122.21.3360.3360

Published: 2013

Journal Articles

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, Margaret Kasner, John L. Wagner, Beth Colombe, Patricia Cornett Farley, William O'Hara, Phyllis Flomenberg, Maria Werner-Wasik, Janet Brunner, Bijoyesh Mookerjee, Terry Hyslop, Mark Weiss, Neal Flomenberg

Blood (2011) 118 (17): 4732–4739.

https://doi.org/10.1182/blood-2011-07-365338

Published: 2011

Journal Articles

Haploidentical Transplantation In Adults ≥ 66 Years of Age

Dolores Grosso, DNP, Onder Alpdogan, MD, Emmanuel C. Besa, MD, Matthew Carabasi, MD, Beth Colombe, PhD, Patricia Cornett Farley, BSc, Joanne Filicko-O'Hara, MD, Elena Gitelson, MD, Margaret Kasner, MD, Ubaldo Martinez-Outshoorn, MD, William O'Hara, PharmD, John L. Wagner, MD, Mark Weiss, MD, Neal Flomenberg, MD

Blood (2010) 116 (21): 3529.

https://doi.org/10.1182/blood.V116.21.3529.3529

Published: 2010

Journal Articles

A Two Step Myeloablative Approach to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematological Malignancies From HLA Partially-Matched (Haploidentical) Related Donors.

Dolores Grosso, DNP, Matthew Carabasi, MD, Janet Brunner, PA-C, Beth Colombe, PhD, Joanne Filicko-O'Hara, MD, Eileen C Finnegan, CRNP, Phyllis Flomenberg, MD, Margaret Kasner, MD, Bijoyesh Mookerjee, MD, William O'Hara PharmD, Nyree Tedesco-Garafano, CRNP, John L. Wagner, MD, Maria Werner-Wasik, MD, Neal Flomenberg, MD, FACP

Blood (2009) 114 (22): 2292.

https://doi.org/10.1182/blood.V114.22.2292.2292

Published: 2009

NARROW

Cardiac Toxicity in Recipients of Hematopoietic Stem Cell Transplant with Post Transplant Cyclophosphamide

Letermovir Prophylaxis Is Effective in Preventing CMV Reactivation and Is Associated with Decreased Non-Relapse Mortality in Two-Step Allogeneic Stem Cell Transplantation

TBI-Based Myeloablative Conditioning Two-Step Haploidentical Allogeneic Hematopoietic Stem Cell Transplant Yields Excellent Outcomes in Fit Patients with High-Risk Hematologic Malignancies, Results of a Prospective Trial

A Novel Chemo-Based Reduced Intensity Haploidentical Two-Step Allogeneic Hematopoietic Stem Cell Transplantation, Results of a Prospective Clinical Trial

Low Disease Relapse and High Survival in Non-Myeloablative Two-Step Haploidentical Transplant, Results of a Prospective Trial

Outcome of Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplant with Post-Transplant Cyclophosphamide - a Single Center Experience

Characteristics and Clinical Outcomes of Patients with Acute Myeloid Leukemia with TP53 Mutations - a Single Center Experience

The Two-Step Approach to Haploidentical Transplant: Can Altering Timing in the Conditioning Regimen Increase Graft Versus Tumor Effects?

Encouraging Results of Haploidentical Transplantation in Older Patents Using the Two-Step T Cell Tolerization Platform - Results of a Prospective Trial

The Two-Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation (HI HSCT): 15 Years of Transplants in Patients 19-78 Years Old

High Survival in Patients with Myelofibrosis Undergoing a Two-Step Approach to Hematopoietic Stem Cell Transplantation (HSCT): Effects of Donor Source and Pre-HSCT Splenic Therapy on Outcomes

2 Step Myeloablative Haploidentical Transplant (HI MA HSCT) in Intermediate and High-Risk Patients-Changing the Timing of the 2 Step Approach

HSCT Engraftment Kinetics: Differences in Chimerism between Haploidentical (HI) and Matched Related (MR) Transplant Recipients (HSCT) after the 2 Step Approach

The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)

A 2 Step Approach To Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation (HSCT): Low Non-Relapse Related Mortality (NRM) and High Overall Survival (OS) Rates Confirmed In Second Generation Trial

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

Haploidentical Transplantation In Adults ≥ 66 Years of Age

A Two Step Myeloablative Approach to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Hematological Malignancies From HLA Partially-Matched (Haploidentical) Related Donors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only